Artivion, the Atlanta-based maker of heart-focused medical devices, has taken full ownership of its longtime Austin base, buying roughly 160,000 square feet of property in a deal pegged at about $20.3 million. The purchase turns buildings the company had been leasing for its On-X heart-valve operations into company-owned facilities and signals a confident bet on ramping up local production.
According to the Austin Business Journal, the company paid roughly $20.3 million for properties totaling about 160,000 square feet. Financial outlets that summarized Artivion’s securities filings, including StreetInsider, noted that the two agreement prices added up to about $20.5 million.
Deal details and filings
Per a Securities and Exchange Commission Form 8-K filing, Artivion entered into two Real Estate Purchase and Sale Contracts on Sept. 26, 2025. One covered about 75,000 square feet and was listed at $12.05 million, and an adjacent building of roughly 87,000 square feet was priced at $8.45 million.
The company’s 2025 Securities and Exchange Commission Form 10-K states that the transactions closed in December 2025 and were capitalized as property, plant and equipment for aggregate cash consideration of approximately $20.3 million. The purchase agreement for the 1200 E. Anderson Lane building, which the contract lists as about 86,910 rentable square feet, is publicly filed online at Justia.
What Artivion will use the buildings for
Artivion’s corporate materials highlight On-X mechanical heart valves and related aortic technologies as core products, and the company says its Austin facilities support On-X manufacturing. Artivion lists the On-X line among its principal offerings and presents the Austin operations as part of its broader manufacturing footprint.
Austin market context
The deal also shows up in local market reporting. Partners Real Estate’s Q4 2025 office market brief lists the 1200 E. Anderson Lane sale among notable transactions and points to continued, selective investment in properties that support medical and manufacturing uses. Partners Real Estate found that while office absorption weakened late last year, targeted move-ins tied to specialized industrial and life-science needs continued.
Taken together, the buys pull Artivion’s Austin footprint fully under company ownership and give the firm more control as it looks to scale On-X production. The company has not released additional public details on hiring plans or specific expansion timelines beyond what appears in its securities filings.
